Table 4. Overall analysis of pathologic and oncological outcomes comparing LRC and ORC.
Outcome of interest | No. of studies | No. of patients, LRC/ORC | OR/WMD (95% CI) | p-value | Study heterogeneity | Egger’s test (p value) | |||
Chi2 | df | I2 | p-value | ||||||
Pathologic stage | |||||||||
pT0,Ta,Tis,T1 | 12 | 413/384 | 1.27 [0.89, 1.82] | 0.19 | 3.22 | 11 | 0% | 0.99 | 0.93 |
pT2 | 14 | 478/467 | 1.13 [0.86, 1.49] | 0.46 | 8.33 | 13 | 0% | 0.81 | 0.0008 |
pT3 | 13 | 463/452 | 0.84 [0.63, 1.14] | 0.27 | 16.52 | 12 | 27% | 0.17 | 0.05 |
pT4 | 8 | 340/300 | 0.59 [0.34, 1.03] | 0.06 | 10.89 | 7 | 36% | 0.14 | 0.31 |
Organ confined ≤pT2 | 14 | 513/502 | 1.33 [1.01, 1.73] | 0.04 | 12.37 | 13 | 0% | 0.50 | 0.02 |
Non-organ confined pT3–T4 | 14 | 513/502 | 0.80 [0.61, 1.06] | 0.12 | 14.92 | 13 | 13% | 0.31 | 0.01 |
Pathologic grade | |||||||||
Grade 1 | 5 | 221/193 | 0.92 [0.48, 1.75] | 0.79 | 1.29 | 4 | 0% | 0.86 | 0.37 |
Grade 2 | 7 | 266/243 | 1.34 [0.92, 1.94] | 0.13 | 8.35 | 6 | 28% | 0.21 | 0.05 |
Grade 3 | 7 | 266/243 | 0.78 [0.53, 1.15] | 0.21 | 9.39 | 6 | 36% | 0.15 | 0.19 |
Positive surgical margins | 7 | 334/281 | 0.35 [0.16, 0.73] | 0.006 | 3.31 | 6 | 0% | 0.77 | 0.30 |
Mean lymph node yield, n | 8 | 355/301 | 0.53 [−1.42, 2.48]† | 0.59 | 83.18 | 7 | 92% | <0.001 | 0.95 |
Positive lymph node | 11 | 436/394 | 0.66 [0.44, 1.00] | 0.05 | 7.90 | 10 | 0% | 0.64 | 0.24 |
Local recurrence | 4 | 207/180 | 1.21 [0.37, 3.95] | 0.75 | 2.71 | 3 | 0% | 0.44 | 0.78 |
Distant metastasis | 6 | 254/230 | 0.56 [0.31, 1.01] | 0.05 | 3.67 | 5 | 0% | 0.60 | 0.85 |
Cancer-free survival | 4 | 189/147 | 1.11 [0.66, 1.86] | 0.69 | 1.36 | 3 | 0% | 0.71 | 0.81 |
Death | 6 | 238/218 | 0.42 [0.23, 0.76] | 0.004 | 3.78 | 5 | 0% | 0.58 | 0.90 |
CI, Confidence interval; OR, odds ratio; WMD, weighted mean difference; LRC = laparoscopic radical cystectomy; ORC = open radical cystectomy.
Values of WMD;
*Statistically significant results are shown in bold.